| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 PCDHB5 TBC1D8B TBC1D9 DUOX1 FAT2 CABP4 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 RUNX1 SYT10 PCDHB16 CAMKK2 CELSR3 DCHS1 LTBP2 CDH4 PCDHGC3 | 3.94e-09 | 749 | 233 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | HIP1 FRMPD4 OBSCN LANCL2 FCHSD2 OSBPL5 ARAP2 PLEKHA4 JPH2 ARHGAP9 AMER3 SYT10 | 4.04e-06 | 199 | 233 | 12 | GO:1901981 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | HIP1 FRMPD4 OBSCN LANCL2 FCHSD2 ZFYVE9 OSBPL5 PLD1 ARAP2 PLEKHA4 JPH2 ARHGAP9 AMER3 SYT10 | 2.22e-05 | 316 | 233 | 14 | GO:0035091 |
| GeneOntologyMolecularFunction | beta-catenin binding | 8.34e-05 | 120 | 233 | 8 | GO:0008013 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | OBSCN BCR TBC1D8B TBC1D9 DOCK5 ARAP2 DOCK3 ARHGEF5 RGL3 RALGPS2 PSD3 ARHGAP9 ARHGAP39 RGS3 RGS12 DENND4C ARHGAP28 | 1.02e-04 | 507 | 233 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | OBSCN BCR TBC1D8B TBC1D9 DOCK5 ARAP2 DOCK3 ARHGEF5 RGL3 RALGPS2 PSD3 ARHGAP9 ARHGAP39 RGS3 RGS12 DENND4C ARHGAP28 | 1.02e-04 | 507 | 233 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 1.24e-04 | 95 | 233 | 7 | GO:0005546 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.88e-04 | 25 | 233 | 4 | GO:0033691 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 2.36e-04 | 48 | 233 | 5 | GO:0032266 | |
| GeneOntologyMolecularFunction | phospholipid binding | HIP1 FRMPD4 SPTBN2 OBSCN LANCL2 GRAMD1B FCHSD2 ZFYVE9 OSBPL5 PLD1 ARAP2 CARMIL2 PLEKHA4 JPH2 ARHGAP9 AMER3 SYT10 | 2.55e-04 | 548 | 233 | 17 | GO:0005543 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.60e-04 | 49 | 233 | 5 | GO:0005547 | |
| GeneOntologyMolecularFunction | GTPase activator activity | BCR TBC1D8B TBC1D9 DOCK5 ARAP2 DOCK3 ARHGAP9 ARHGAP39 RGS3 RGS12 ARHGAP28 | 4.58e-04 | 279 | 233 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 5.51e-04 | 121 | 233 | 7 | GO:1902936 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 7.12e-04 | 35 | 233 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 7.94e-04 | 36 | 233 | 4 | GO:0070273 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.12e-03 | 18 | 233 | 3 | GO:0015347 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDHB5 FAT2 NECTIN2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 1.66e-17 | 187 | 232 | 23 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG DCHS2 PCDHB5 FAT2 NECTIN2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 CLDN23 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 1.78e-14 | 313 | 232 | 25 | GO:0098742 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB4 PCDHB3 PCDHB16 DCHS1 CDH4 PCDHGC3 | 1.45e-11 | 53 | 232 | 11 | GO:0016339 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG SOX12 DCHS2 PCDHB5 PKD1L1 ITGAE ITPKB FAT2 GLI3 NECTIN2 PLG PCDH10 DPP4 MIA3 CARMIL2 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 MINK1 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 LAMA3 RUNX1 CLDN23 PCDHB16 CELSR3 EGFR DCHS1 SIGLEC1 FUT4 CDH4 PCDHGC3 | 2.29e-11 | 1077 | 232 | 40 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 FRMPD4 PCDHB5 SPTBN2 THSD1 CSMD2 BCR SHISA6 PCDHGC5 PCDHGC4 TNC PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB4 PCDHB3 APC LAMA3 NBEA ARHGAP39 SHROOM2 CLDN23 PCDHB16 SHANK2 CNTNAP2 SEPTIN11 POLDIP2 CDH4 PCDHGC3 | 5.66e-07 | 974 | 232 | 30 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 FRMPD4 PCDHB5 SPTBN2 CSMD2 SHISA6 PCDHGC5 PCDHGC4 TNC PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB4 PCDHB3 NBEA ARHGAP39 PCDHB16 SHANK2 CNTNAP2 SEPTIN11 PCDHGC3 | 1.06e-05 | 685 | 232 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction assembly | PCDHB5 SPTBN2 THSD1 CSMD2 BCR PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB4 PCDHB3 APC LAMA3 CLDN23 PCDHB16 SHANK2 CNTNAP2 POLDIP2 CDH4 | 2.56e-05 | 569 | 232 | 19 | GO:0034329 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 ATP7B PCDHB5 SPTBN2 OBSCN THSD1 MAST2 ERBIN MPRIP DOCK5 FCHSD2 FAT2 PTPN12 UBN1 NECTIN2 DPP4 CARMIL2 TNC ARHGEF5 APC LAMA3 SHROOM2 CLDN23 TGFB1I1 EGFR CNTNAP2 POLDIP2 CDH4 PCDHGC3 | 1.40e-06 | 976 | 232 | 29 | GO:0070161 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 HIP1 FRMPD4 SYN3 SPTBN2 CSMD2 BCR ERBIN RNF10 PLG PCDH10 SHISA6 PRUNE2 PSD3 APC NBEA ARHGAP39 SYT10 SHANK2 CELSR3 CNTNAP2 SEPTIN11 ATP2B3 | 4.30e-05 | 817 | 232 | 23 | GO:0098978 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | CTSC COL6A5 ADAM11 ERBIN FREM1 PLG COL6A6 TNC GDF15 LAMA3 RUNX1 ITIH5 TGFB1I1 LTBP2 ELN CTSB SOD3 | 9.53e-05 | 530 | 232 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 ATP7B PCDHB5 SPTBN2 OBSCN FAT2 UBN1 NECTIN2 DPP4 CARMIL2 APC LAMA3 SHROOM2 CLDN23 CNTNAP2 POLDIP2 CDH4 PCDHGC3 | 1.14e-04 | 591 | 232 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | extracellular matrix | CTSC COL6A5 ADAM11 ERBIN FREM1 OLFML2A PLG COL6A6 TNC GDF15 LAMA3 RUNX1 ITIH5 TGFB1I1 OVGP1 LTBP2 ELN CTSB SOD3 | 1.41e-04 | 656 | 232 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CTSC COL6A5 ADAM11 ERBIN FREM1 OLFML2A PLG COL6A6 TNC GDF15 LAMA3 RUNX1 ITIH5 TGFB1I1 OVGP1 LTBP2 ELN CTSB SOD3 | 1.47e-04 | 658 | 232 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | beta-catenin-TCF7L2 complex | 3.65e-04 | 3 | 232 | 2 | GO:0070369 | |
| GeneOntologyCellularComponent | catenin-TCF7L2 complex | 7.25e-04 | 4 | 232 | 2 | GO:0071664 | |
| Domain | Cadherin | DCHS2 PCDHB5 FREM1 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 3.02e-21 | 118 | 232 | 23 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 1.01e-20 | 109 | 232 | 22 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 2.34e-20 | 113 | 232 | 22 | PS00232 |
| Domain | Cadherin | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 2.34e-20 | 113 | 232 | 22 | PF00028 |
| Domain | Cadherin_C | PCDHB5 PCDH10 PCDHGC5 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 2.39e-20 | 42 | 232 | 16 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHB5 PCDH10 PCDHGC5 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 2.39e-20 | 42 | 232 | 16 | PF16492 |
| Domain | CADHERIN_2 | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 2.87e-20 | 114 | 232 | 22 | PS50268 |
| Domain | - | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 2.87e-20 | 114 | 232 | 22 | 2.60.40.60 |
| Domain | CA | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 3.51e-20 | 115 | 232 | 22 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 DCHS1 CDH4 PCDHGC3 | 4.28e-20 | 116 | 232 | 22 | IPR015919 |
| Domain | Cadherin_2 | PCDHB5 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 2.44e-18 | 65 | 232 | 17 | PF08266 |
| Domain | Cadherin_N | PCDHB5 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 2.44e-18 | 65 | 232 | 17 | IPR013164 |
| Domain | PH_dom-like | FRMPD4 SPTBN2 OBSCN BCR LYST MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 NBEA RGS3 RGS12 EPB41L1 | 1.68e-06 | 426 | 232 | 19 | IPR011993 |
| Domain | Cadherin_tail | 5.80e-06 | 37 | 232 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 5.80e-06 | 37 | 232 | 6 | IPR031904 | |
| Domain | PH | SPTBN2 OBSCN BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 | 6.08e-06 | 229 | 232 | 13 | PF00169 |
| Domain | - | SPTBN2 OBSCN BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 RGS3 RGS12 EPB41L1 | 3.26e-05 | 391 | 232 | 16 | 2.30.29.30 |
| Domain | PH | SPTBN2 OBSCN BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 | 4.72e-05 | 278 | 232 | 13 | SM00233 |
| Domain | PH_DOMAIN | SPTBN2 OBSCN BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 | 4.89e-05 | 279 | 232 | 13 | PS50003 |
| Domain | PH_domain | SPTBN2 OBSCN BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 ARHGEF5 RALGPS2 PLEKHA4 PSD3 ARHGAP9 | 5.08e-05 | 280 | 232 | 13 | IPR001849 |
| Domain | PDZ | 6.82e-05 | 141 | 232 | 9 | PF00595 | |
| Domain | PDZ | 9.90e-05 | 148 | 232 | 9 | SM00228 | |
| Domain | - | 1.10e-04 | 150 | 232 | 9 | 2.30.42.10 | |
| Domain | PDZ | 1.15e-04 | 151 | 232 | 9 | PS50106 | |
| Domain | PDZ | 1.21e-04 | 152 | 232 | 9 | IPR001478 | |
| Domain | OA_transporter | 3.83e-04 | 12 | 232 | 3 | IPR004156 | |
| Domain | OATP | 3.83e-04 | 12 | 232 | 3 | PF03137 | |
| Domain | DUF1908 | 9.07e-04 | 4 | 232 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 9.07e-04 | 4 | 232 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 9.07e-04 | 4 | 232 | 2 | IPR023142 | |
| Domain | - | 9.07e-04 | 4 | 232 | 2 | 1.20.1480.20 | |
| Domain | GRAM | 9.40e-04 | 16 | 232 | 3 | SM00568 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 PCDHGC3 | 2.59e-25 | 72 | 236 | 19 | 10380929 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 CELSR3 PCDHGC3 | 2.43e-24 | 80 | 236 | 19 | 10716726 |
| Pubmed | PCDHB5 FAT2 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 5.53e-23 | 77 | 236 | 18 | 10835267 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB5 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 2.53e-22 | 68 | 236 | 17 | 11230163 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB5 PCDH10 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 1.25e-21 | 74 | 236 | 17 | 10817752 |
| Pubmed | PCDHB5 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 | 2.97e-17 | 20 | 236 | 10 | 11322959 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHB5 PCDHGC5 PCDHGA7 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 8.72e-17 | 57 | 236 | 13 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB5 PCDHGC5 PCDHGA7 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 1.12e-16 | 58 | 236 | 13 | 30377227 |
| Pubmed | 4.99e-15 | 13 | 236 | 8 | 12231349 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 TANC2 CCP110 MAST2 BCR LYST ERBIN ITPKB MPRIP STARD9 NECTIN2 RNF10 ARAP2 CARMIL2 INPP5E ARHGEF5 SAMD4B MINK1 RALGPS2 PSD3 USP43 APC SIK3 RGS12 DENND4C C2CD3 CSNK1E PLK4 EPB41L1 AHNAK2 | 2.67e-13 | 861 | 236 | 30 | 36931259 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAG SPTBN2 FMNL2 ERBIN DOCK5 NECTIN2 SLC35A2 PPP1R37 ARAP2 CARMIL2 MINK1 RALGPS2 PSD3 USP43 JPH2 SLC39A10 RGS12 C1orf226 SLC12A4 EGFR SLC20A2 EPB41L1 | 6.81e-11 | 569 | 236 | 22 | 30639242 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 HIP1 INTS1 OBSCN MAML1 MAST2 TTC3 BCR LYST TBC1D9 MPRIP KMT2C TDRD3 UBN1 ZMIZ2 SLC35A2 OSBPL5 DOCK3 SZT2 INPP5E HECTD4 CLDN23 C2CD3 SCAP SHANK2 CELSR3 SLC12A4 LRP3 DOT1L AHNAK2 | 1.27e-10 | 1105 | 236 | 30 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | URI1 OBSCN EVC CHD2 TTC3 BCR ERBIN TERF2IP ITPKB PLEKHH1 DOCK5 KMT2C ZBTB7A NECTIN2 VPS35L OSBPL5 MLPH PRUNE2 MIA3 TCF7L2 SAMD4B MINK1 HECTD4 LAMA3 ARHGAP39 SHROOM2 PCDHB16 SHANK2 EGFR MAST1 SEPTIN11 CFAP69 ZMYM4 EPB41L1 | 6.33e-10 | 1489 | 236 | 34 | 28611215 |
| Pubmed | TANC2 CCP110 SPTBN2 FMNL2 ABCA8 TBC1D9 UBE4A FAT2 DOCK3 PRUNE2 SIN3B ATG14 ARHGAP39 TRAPPC8 MSL2 SETD2 SCAP ARHGAP28 REXO1L1P | 1.51e-09 | 493 | 236 | 19 | 15368895 | |
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 3.05e-08 | 28 | 236 | 6 | 33523829 | |
| Pubmed | 7.98e-08 | 17 | 236 | 5 | 18279309 | ||
| Pubmed | FRMPD4 ERBIN PLEKHH1 GRAMD1B FCHSD2 STARD9 NAV3 PCDH10 ARAP2 PSD3 SLC39A10 PCDHB16 CAMKK2 MAST1 EPB41L1 | 1.49e-07 | 407 | 236 | 15 | 12693553 | |
| Pubmed | TANC2 NCOA3 SPTBN2 TTC3 BCR ERBIN MPRIP TDRD3 ZNF394 ANAPC1 GOLGA3 SIN3B MIA3 MINK1 HECTD4 APC NBEA ARHGAP39 SIK3 SHANK2 DCHS1 SEPTIN11 EPB41L1 | 2.10e-07 | 963 | 236 | 23 | 28671696 | |
| Pubmed | 4.20e-07 | 10 | 236 | 4 | 22969705 | ||
| Pubmed | NCOA3 TBC1D8B PLEKHH1 KMT2C STARD9 GLI3 OSBPL5 RGL3 SHROOM2 RGS3 MAST1 | 6.44e-07 | 233 | 236 | 11 | 37704626 | |
| Pubmed | 8.00e-07 | 147 | 236 | 9 | 16959763 | ||
| Pubmed | JADE3 MAML1 BCR LRCH1 KMT2C OSBPL5 RNF10 CACNA1G SZT2 INPP5E HECTD4 SIK3 CAMKK2 CELSR3 CNTNAP2 ZMYM4 | 8.02e-07 | 529 | 236 | 16 | 14621295 | |
| Pubmed | HIP1 INTS1 MAML1 CHD2 ERBIN TERF2IP MPRIP KMT2C ZBTB7A TDRD3 ANAPC1 SLC5A6 SIN3B RBM4B SAMD4B MINK1 PCDHB7 APC ARHGAP39 TFAP2C PLPP6 MSL2 CCNT1 SETD2 SHANK2 SEPTIN11 ZMYM4 EPB41L1 | 1.34e-06 | 1497 | 236 | 28 | 31527615 | |
| Pubmed | 2.31e-06 | 167 | 236 | 9 | 22159717 | ||
| Pubmed | DCHS2 SPTBN2 NCKAP5 TTC3 FMNL2 TERF2IP MPRIP PLEKHH1 UBE4A VPS35L RNF10 NAV3 GOLGA3 DOCK3 HECTD4 APC NBEA RUNX1 SHROOM2 CBS CELSR3 MAST1 POLDIP2 CTSB ZMYM4 | 2.59e-06 | 1285 | 236 | 25 | 35914814 | |
| Pubmed | 2.66e-06 | 15 | 236 | 4 | 34835087 | ||
| Pubmed | Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. | 3.05e-06 | 5 | 236 | 3 | 16007074 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPTBN2 INTS1 OBSCN CHD2 CSMD2 ITGAE FMNL2 DOCK5 KMT2C TDRD3 PCDH10 SIN3B PCDHB14 PCDHB12 ARHGAP9 NBEA AMER3 TGFB1I1 | 3.35e-06 | 736 | 236 | 18 | 29676528 |
| Pubmed | 3.40e-06 | 175 | 236 | 9 | 28071719 | ||
| Pubmed | LRCH1 ERBIN KMT2C RNF10 CACNA1G PRUNE2 PSD3 SIK3 CAMKK2 SCAP | 3.59e-06 | 225 | 236 | 10 | 12168954 | |
| Pubmed | TANC2 FRMPD4 SYN3 BCR ERBIN GRAMD1B RNF10 NAV3 SHISA6 DOCK3 MIA3 MINK1 PSD3 APC NBEA TACC2 ARHGAP39 SHROOM2 SHANK2 CSNK1E CNTNAP2 SEPTIN11 EPB41L1 | 3.63e-06 | 1139 | 236 | 23 | 36417873 | |
| Pubmed | IGSF8 MAG TANC2 SYN3 SPTBN2 BCR FMNL2 ERBIN LANCL2 ITPKB MPRIP GRAMD1B GOLGA3 CARMIL2 TNC MINK1 PSD3 APC NBEA ARHGAP39 SHROOM2 SHANK2 MAST1 SEPTIN11 ATP2B3 EPB41L1 | 5.51e-06 | 1431 | 236 | 26 | 37142655 | |
| Pubmed | Wnt1 signal determines the patterning of the diencephalic dorso-ventral axis. | 6.08e-06 | 6 | 236 | 3 | 26452989 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 32372448 | ||
| Pubmed | MAML1 FMNL2 ERBIN DOCK5 GLI3 NECTIN2 DCLRE1A PLD1 PCDH10 GOLGA3 ARAP2 MINK1 APC MUC16 NBEA SLC39A10 EGFR AP4M1 | 7.03e-06 | 777 | 236 | 18 | 35844135 | |
| Pubmed | LRCH1 ERBIN MPRIP ZFYVE9 NECTIN2 PPP1R37 GOLGA3 MINK1 PSD3 SLC39A10 C1orf226 EGFR EPB41L1 | 7.06e-06 | 421 | 236 | 13 | 36976175 | |
| Pubmed | MAG HIP1 LRCH1 ERBIN STARD9 TUBGCP3 TNC APC ARHGAP39 CSNK1E MAST1 SEPTIN11 EPB41L1 | 8.84e-06 | 430 | 236 | 13 | 32581705 | |
| Pubmed | Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions. | 9.19e-06 | 20 | 236 | 4 | 16971467 | |
| Pubmed | 9.19e-06 | 20 | 236 | 4 | 20637749 | ||
| Pubmed | 1.01e-05 | 152 | 236 | 8 | 38360978 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 23677475 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 16059920 | ||
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.06e-05 | 7 | 236 | 3 | 9182820 | |
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 15048729 | ||
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 1.06e-05 | 7 | 236 | 3 | 18276594 | |
| Pubmed | [Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins]. | 1.06e-05 | 7 | 236 | 3 | 18453149 | |
| Pubmed | PABIR1 URI1 SPTBN2 ERBIN TDRD3 PTPN12 ZFYVE9 NECTIN2 PPP1R37 MIA3 MINK1 PSD3 NBEA ARHGAP39 SLC39A10 C2CD3 C1orf226 SLC12A4 EGFR PLK4 EPB41L1 | 1.12e-05 | 1049 | 236 | 21 | 27880917 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ERBIN SLC5A6 NECTIN2 SLC35A2 MINK1 PSD3 SLC39A10 SLC12A4 SLC20A2 SEPTIN11 ATP2B3 EPB41L1 | 1.18e-05 | 377 | 236 | 12 | 38117590 |
| Pubmed | 1.37e-05 | 22 | 236 | 4 | 25587709 | ||
| Pubmed | 1.42e-05 | 209 | 236 | 9 | 36779422 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | JADE3 INTS1 CHD2 BCR LYST MPRIP GRAMD1B PTPN12 ANAPC1 TANK RBM4B SGK1 MINK1 SIK3 CCNT1 CAMKK2 EGFR CSNK1E PLK4 | 1.67e-05 | 910 | 236 | 19 | 36736316 |
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 21383188 | ||
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 1.68e-05 | 8 | 236 | 3 | 32179550 | |
| Pubmed | Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. | 1.68e-05 | 8 | 236 | 3 | 22056988 | |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | INTS1 SIGLEC5 THSD1 IL22RA1 SIGLEC12 KLK11 MIA3 PCDHB13 PCDHB10 PCDHB9 SIGLEC14 MUC16 ITIH5 | 1.80e-05 | 460 | 236 | 13 | 20562862 |
| Pubmed | OBSCN GATA6 CHD2 TTC3 ERBIN LANCL2 KMT2C VPS35L PLD1 NPAT MIA3 INPP5E RALGPS2 APC TACC2 SLC39A10 SHROOM2 SCAP CSNK1E SEPTIN11 DOT1L | 1.81e-05 | 1084 | 236 | 21 | 11544199 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MAG INTS1 MAST2 TTC3 TDRD3 OSBPL5 PLD1 RBM4B SAMD4B PLPP6 EXOC5 C2CD3 EGFR | 1.88e-05 | 462 | 236 | 13 | 31138677 |
| Pubmed | IGSF8 DBP MAST2 ERBIN GRAMD1B PTPN12 CABP4 NAV3 SIN3B TCF7L2 PGGHG SGK1 PSD3 APC TACC2 EBF1 RNASEL MAST1 CDH4 ZMYM4 | 2.01e-05 | 1006 | 236 | 20 | 15226823 | |
| Pubmed | Tissue-specific activities of the Fat1 cadherin cooperate to control neuromuscular morphogenesis. | 2.34e-05 | 25 | 236 | 4 | 29768404 | |
| Pubmed | 2.51e-05 | 9 | 236 | 3 | 12874278 | ||
| Pubmed | 2.51e-05 | 9 | 236 | 3 | 10607900 | ||
| Pubmed | 2.71e-05 | 127 | 236 | 7 | 30442766 | ||
| Pubmed | TANC2 SYN3 TNC MINK1 APC NBEA ARHGAP39 PLPP6 CAMKK2 SHANK2 EPB41L1 | 2.84e-05 | 347 | 236 | 11 | 17114649 | |
| Pubmed | 3.33e-05 | 54 | 236 | 5 | 36237976 | ||
| Pubmed | TANC2 NCOA3 MAML1 CHD2 CSMD2 ITPKB PLEKHH1 TNC MUC16 ATG14 NBEA SIK3 CTSB ATP2B3 AHNAK2 | 3.50e-05 | 638 | 236 | 15 | 31182584 | |
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 3.57e-05 | 10 | 236 | 3 | 9027500 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTBN2 FMNL2 ERBIN MPRIP NECTIN2 PPP1R37 GOLGA3 MINK1 USP43 DENND4C SHANK2 EGFR CTSB EPB41L1 | 3.64e-05 | 565 | 236 | 14 | 25468996 |
| Pubmed | 3.72e-05 | 28 | 236 | 4 | 15917450 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.02e-05 | 135 | 236 | 7 | 28675934 | |
| Pubmed | Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. | 4.53e-05 | 94 | 236 | 6 | 20346360 | |
| Pubmed | GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. | 4.59e-05 | 2 | 236 | 2 | 18177748 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 24799499 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 11459228 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 33605506 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 36878305 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 15985311 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 17440072 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 10092676 | ||
| Pubmed | PLK4 phosphorylation of CP110 is required for efficient centriole assembly. | 4.59e-05 | 2 | 236 | 2 | 28562169 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 19647224 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 33054062 | ||
| Pubmed | Extracellular matrix proteins: a positive feedback loop in lung fibrosis? | 4.59e-05 | 2 | 236 | 2 | 24291458 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 19263440 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 21878490 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 26459514 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 25016703 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22226732 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 18698347 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 21653642 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 31160382 | ||
| Pubmed | Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC. | 4.59e-05 | 2 | 236 | 2 | 19494170 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22566624 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 18941509 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 35853851 | ||
| Pubmed | A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. | 4.59e-05 | 2 | 236 | 2 | 21469119 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 20882040 | ||
| Pubmed | Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer. | 4.59e-05 | 2 | 236 | 2 | 30614797 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 27793841 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 34580284 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 30134935 | ||
| Interaction | YWHAB interactions | PABIR1 TANC2 CCP110 URI1 MAST2 BCR LYST ERBIN ITPKB MPRIP STARD9 NECTIN2 ARAP2 CARMIL2 INPP5E ARHGEF5 SAMD4B MINK1 HECTD4 RALGPS2 PLEKHA4 PSD3 USP43 APC SIK3 TRAPPC8 RGS3 RGS12 DENND4C EGFR CSNK1E MAST1 DOT1L PLK4 EPB41L1 AHNAK2 | 2.36e-09 | 1014 | 235 | 36 | int:YWHAB |
| Interaction | YWHAZ interactions | PABIR1 TANC2 CCP110 SPTBN2 MAST2 BCR LRCH1 LYST ERBIN MPRIP GRAMD1B STARD9 NECTIN2 GOLGA3 ARAP2 CARMIL2 COL6A6 SGK1 INPP5E ARHGEF5 SAMD4B MINK1 HECTD4 RALGPS2 PLEKHA4 PSD3 USP43 APC ZNF397 TACC2 SIK3 RGS3 RGS12 DENND4C MSL2 EXOC5 EGFR CSNK1E MAST1 PLK4 EPB41L1 | 7.57e-09 | 1319 | 235 | 41 | int:YWHAZ |
| Interaction | YWHAH interactions | PABIR1 TANC2 CCP110 NCOA3 MAST2 BCR LYST ERBIN MPRIP STARD9 NECTIN2 OSBPL5 RNF10 DCLRE1A ARAP2 CARMIL2 INPP5E ARHGEF5 SAMD4B MINK1 HECTD4 RALGPS2 PLEKHA4 PSD3 USP43 APC SIK3 RGS12 DENND4C C2CD3 CSNK1E MAST1 PLK4 EPB41L1 AHNAK2 | 6.60e-08 | 1102 | 235 | 35 | int:YWHAH |
| Interaction | YWHAQ interactions | PABIR1 TANC2 CCP110 NCOA3 MAST2 BCR LYST ERBIN MPRIP STARD9 TUBGCP3 NECTIN2 PLG ARAP2 CARMIL2 MAT2B SGK1 ARHGEF5 SAMD4B MINK1 HECTD4 RALGPS2 PLEKHA4 PSD3 USP43 APC SIK3 RGS3 RGS12 DENND4C EGFR CSNK1E PLK4 EPB41L1 | 2.88e-07 | 1118 | 235 | 34 | int:YWHAQ |
| Interaction | HRAS interactions | FMNL2 IL22RA1 ERBIN DOCK5 ANAPC1 NECTIN2 SLC35A2 PPP1R37 ARAP2 TCF4 SGK1 RGL3 MINK1 RALGPS2 USP43 APC JPH2 SLC39A10 RGS12 C1orf226 SLC12A4 EGFR SLC20A2 SEPTIN11 PCDHGC3 EPB41L1 | 3.98e-07 | 725 | 235 | 26 | int:HRAS |
| Interaction | OCLN interactions | IGSF8 SPTBN2 ERBIN ZFYVE9 NECTIN2 PCDH10 GOLGA3 ARAP2 DPP4 MIA3 MINK1 PLEKHA4 PSD3 APC NBEA ARHGAP39 SLC39A10 C1orf226 EGFR CSNK1E EPB41L1 | 4.55e-07 | 500 | 235 | 21 | int:OCLN |
| Interaction | YWHAE interactions | PABIR1 TANC2 SYN3 COL6A5 MAST2 TTC3 BCR LRCH1 LYST ERBIN LANCL2 MPRIP GOLGA3 ARAP2 CARMIL2 INPP5E ARHGEF5 SAMD4B MINK1 RALGPS2 PLEKHA4 PSD3 USP43 APC TACC2 SIK3 SHROOM2 RGS3 RGS12 DENND4C MSL2 CSNK1E MAST1 DOT1L PLK4 EPB41L1 | 5.14e-07 | 1256 | 235 | 36 | int:YWHAE |
| Interaction | PCDHB3 interactions | PCDHB5 PCDHGA5 PCDHB13 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 SCAP EGFR | 8.34e-07 | 141 | 235 | 11 | int:PCDHB3 |
| Interaction | PCDHGB1 interactions | 3.19e-06 | 77 | 235 | 8 | int:PCDHGB1 | |
| Interaction | YWHAG interactions | PABIR1 TANC2 CCP110 MAST2 BCR LYST ERBIN ITPKB MPRIP STARD9 NECTIN2 ARAP2 CARMIL2 INPP5E ARHGEF5 SAMD4B MINK1 HECTD4 RALGPS2 PLEKHA4 PSD3 USP43 APC ZNF397 SIK3 SHROOM2 RGS12 DENND4C MSL2 C2CD3 CSNK1E PLK4 EPB41L1 AHNAK2 | 3.40e-06 | 1248 | 235 | 34 | int:YWHAG |
| Interaction | GJA1 interactions | THSD1 ERBIN ZFYVE9 SCN4A NECTIN2 GOLGA3 ARAP2 MIA3 MINK1 PSD3 APC ATG14 NBEA SLC39A10 TRAPPC8 DENND4C C1orf226 SLC12A4 EGFR PLK4 EPB41L1 | 5.17e-06 | 583 | 235 | 21 | int:GJA1 |
| Interaction | LYN interactions | CCP110 FRMPD4 SPTBN2 FMNL2 ERBIN NECTIN2 PLD1 ARAP2 PRUNE2 DPP4 ARHGEF5 MINK1 PLEKHA4 PSD3 APC ARHGAP39 SLC39A10 DENND4C SLC12A4 EGFR SLC20A2 EPB41L1 AHNAK2 | 1.29e-05 | 720 | 235 | 23 | int:LYN |
| Interaction | ARL4C interactions | 3.17e-05 | 136 | 235 | 9 | int:ARL4C | |
| Interaction | RETSAT interactions | 3.43e-05 | 106 | 235 | 8 | int:RETSAT | |
| Interaction | FLOT1 interactions | SPTBN2 FMNL2 ERBIN ZFYVE9 NECTIN2 MINK1 PLEKHA4 PSD3 APC ARHGAP39 SLC39A10 C1orf226 SLC12A4 EGFR CNTNAP2 DOT1L EPB41L1 | 4.56e-05 | 475 | 235 | 17 | int:FLOT1 |
| Interaction | DLGAP1 interactions | SPTBN2 ERBIN MPRIP MINK1 APC NBEA ARHGAP39 SHANK2 SEPTIN11 EPB41L1 | 5.20e-05 | 180 | 235 | 10 | int:DLGAP1 |
| Interaction | PCDHB10 interactions | 5.29e-05 | 7 | 235 | 3 | int:PCDHB10 | |
| Interaction | ARF6 interactions | SPTBN2 FMNL2 ERBIN ZFYVE9 NECTIN2 PLD1 ARAP2 DPP4 MINK1 PLEKHA4 PSD3 SLC39A10 DENND4C EXOC5 SLC12A4 EGFR SLC20A2 SEPTIN11 EPB41L1 | 5.89e-05 | 584 | 235 | 19 | int:ARF6 |
| Interaction | DIRAS3 interactions | HIP1 SPTBN2 NECTIN2 GOLGA3 PSD3 APC ATG14 NBEA SLC39A10 SLC12A4 EGFR EPB41L1 | 6.23e-05 | 262 | 235 | 12 | int:DIRAS3 |
| Interaction | SFN interactions | PABIR1 TANC2 CCP110 MAST2 BCR LYST ERBIN MPRIP ARAP2 ARHGEF5 MINK1 RALGPS2 APC SIK3 TEX14 RGS12 DENND4C CAMKK2 EGFR PLK4 AHNAK2 | 6.52e-05 | 692 | 235 | 21 | int:SFN |
| Interaction | ARL14 interactions | 7.83e-05 | 119 | 235 | 8 | int:ARL14 | |
| Interaction | GJD3 interactions | HIP1 ATP7B SPTBN2 FMNL2 ERBIN ZFYVE9 NECTIN2 SLC35A2 PLD1 GOLGA3 MIA3 MINK1 SLC39A10 TRAPPC8 EGFR SLC20A2 | 9.14e-05 | 454 | 235 | 16 | int:GJD3 |
| Interaction | TOP3B interactions | TANC2 HIP1 SPTBN2 INTS1 OBSCN MAML1 MAST2 TTC3 BCR LYST TBC1D9 MPRIP KMT2C TDRD3 UBN1 ZMIZ2 SLC35A2 OSBPL5 DOCK3 SZT2 INPP5E SAMD4B HECTD4 PLEKHA4 CLDN23 C2CD3 SCAP SHANK2 CELSR3 SLC12A4 LRP3 DOT1L DCAF4 AHNAK2 | 9.85e-05 | 1470 | 235 | 34 | int:TOP3B |
| Interaction | PCDHB16 interactions | 1.10e-04 | 41 | 235 | 5 | int:PCDHB16 | |
| Interaction | SMARCA4 interactions | MAML1 TTC3 TERF2IP ZBTB7A TFCP2L1 UBN1 CIITA GLI3 ZMIZ2 SIN3B PLEKHA4 SIK3 RUNX1 EGFR CSNK1E DOT1L | 1.12e-04 | 462 | 235 | 16 | int:SMARCA4 |
| Interaction | LAMTOR1 interactions | CCP110 ATP7B SPTBN2 FMNL2 TBC1D9 ZFYVE9 NECTIN2 PPP1R37 PLD1 GOLGA3 SZT2 MINK1 PSD3 NBEA SLC39A10 TRAPPC8 DENND4C C1orf226 SLC12A4 EGFR SLC20A2 | 1.18e-04 | 722 | 235 | 21 | int:LAMTOR1 |
| Cytoband | 5q31 | PCDHB5 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 1.36e-18 | 115 | 236 | 16 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHB5 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 4.86e-12 | 298 | 236 | 16 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHB5 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB7 PCDHB4 PCDHB3 PCDHB16 PCDHGC3 | 5.46e-19 | 64 | 169 | 16 | 20 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTBN2 BCR MPRIP PLEKHH1 OSBPL5 PLD1 ARAP2 RALGPS2 PLEKHA4 PSD3 ARHGAP9 | 3.86e-06 | 206 | 169 | 11 | 682 |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 5.55e-06 | 28 | 169 | 5 | 745 | |
| GeneFamily | PDZ domain containing | 1.32e-05 | 152 | 169 | 9 | 1220 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 2.14e-04 | 13 | 169 | 3 | 1146 | |
| GeneFamily | Cadherin related | 4.95e-04 | 17 | 169 | 3 | 24 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 5.18e-04 | 40 | 169 | 4 | 592 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.99e-03 | 9 | 169 | 2 | 1230 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 FRMPD4 SYN3 SLCO3A1 CSMD2 TTC3 FMNL2 LYST LANCL2 TERF2IP TBC1D9 FAT2 KIAA1549L CABP4 NAV3 CACNA1G GOLGA3 DOCK3 MIA3 COL6A6 PCDHB4 APC LAMA3 NBEA EBF1 AMER3 SIK3 SHROOM2 LHX1 SHANK2 CELSR3 CNTNAP2 MAST1 PAPPA CDH4 EPB41L1 AHNAK2 | 5.47e-12 | 1106 | 236 | 37 | M39071 |
| Coexpression | HAY_BONE_MARROW_STROMAL | PCDHB5 NCKAP5 ABCA8 OLFML2A HOXC9 GLI3 NECTIN2 NAV3 TNC PCDHGA2 RGL3 PCDHB14 PCDHB12 PCDHB10 PLEKHA4 PCDHB7 TACC2 RUNX1 RGS3 PCDHB16 ITIH5 EGFR PAPPA ARHGAP28 LTBP2 TRIM47 SOD3 | 1.77e-09 | 767 | 236 | 27 | M39209 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PABIR1 TANC2 SPTBN2 GATA6 LRCH1 TBC1D9 C9orf152 NECTIN2 PCDH10 MLPH TCF4 GDF15 SGK1 PCDHB14 PCDHB10 PCDHB7 PSD3 NBEA SHROOM2 PCDHB16 SHANK2 LTBP2 EPB41L1 | 8.00e-07 | 786 | 236 | 23 | M10961 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | TANC2 DCHS2 URI1 OBSCN SLCO3A1 COL6A5 ADAM11 KMT2C FCHSD2 DUOX1 FAT2 CIITA PLG MLPH DOCK3 DPP4 PCDHGA2 PSD3 ITIH5 SLCO5A1 SLC20A2 CDH4 REXO1L1P ZMYM4 | 1.36e-06 | 873 | 236 | 24 | M16009 |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | DOCK5 RNF10 ARAP2 DPP4 HECTD4 RALGPS2 RGS12 ITIH5 DOT1L CTSB DCAF4 | 2.18e-06 | 200 | 236 | 11 | M3236 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 URI1 MAST2 TDRD3 FCHSD2 PTPN12 ZFYVE9 TUBGCP3 NAV3 ARAP2 NPAT TCF7L2 TANK PSD3 APC SIK3 RUNX1 TRAPPC8 SETD2 C2CD3 EGFR SLC20A2 ZMYM4 | 3.35e-06 | 856 | 236 | 23 | M4500 |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | CHD2 LYST GRAMD1B UBE4A CIITA ZMIZ2 NECTIN2 SIN3B SEPTIN11 DOT1L | 1.46e-05 | 200 | 236 | 10 | M8635 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ATP7B GATA6 ERBIN ITPKB DOCK5 TFCP2L1 GLI3 NECTIN2 SHISA6 TCF7L2 EBF1 RUNX1 CBS CLDN23 SLCO5A1 SLC12A4 EGFR PTCH2 MAST1 PAPPA ARHGAP28 FUT4 LY75 TRIM47 EPB41L1 | 1.48e-05 | 1074 | 236 | 25 | M1941 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | CTSC SLCO3A1 TERF2IP CACNA1G APC NBEA AMER3 LHX1 SHANK2 CELSR3 CNTNAP2 MAST1 PAPPA DOT1L CDH4 | 2.32e-05 | 465 | 236 | 15 | M39066 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | TANC2 HIP1 NCKAP5 CHD2 CSMD2 GRAMD1B UBN1 PLG SHISA6 PRUNE2 RGL3 RUNX1 SHANK2 CNTNAP2 | 2.82e-05 | 417 | 236 | 14 | M39224 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | NCOA3 CTSC GATA6 EVC THSD1 CPED1 LYST ZMIZ2 TCF4 MIA3 TANK MAT2B TNC GDF15 SGK1 PLEKHA4 LAMA3 ARHGAP39 ITIH5 SHANK2 TRIM47 CTSB AHNAK2 | 6.51e-05 | 1033 | 236 | 23 | M4196 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | FRMPD4 CSMD2 GOLGA3 DOCK3 PCDHB4 TACC2 AMER3 SHROOM2 SHANK2 CNTNAP2 MAST1 PAPPA ARHGAP28 CDH4 EPB41L1 | 7.07e-05 | 513 | 236 | 15 | M39069 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | JADE3 OBSCN SLCO3A1 MAST2 LYST DOCK5 TFCP2L1 ZMIZ2 NECTIN2 SLC35A2 DLEC1 NPAT DNAJC4 GDF15 RUNX1 CSNK1E ELN CDH4 PCDHGC3 DCAF4 SOD3 | 8.19e-05 | 909 | 236 | 21 | M41018 |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP | 8.21e-05 | 198 | 236 | 9 | M4596 | |
| Coexpression | GSE29618_PDC_VS_MDC_UP | 8.21e-05 | 198 | 236 | 9 | M4951 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 8.86e-05 | 200 | 236 | 9 | M302 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 8.86e-05 | 200 | 236 | 9 | M4805 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP | 8.86e-05 | 200 | 236 | 9 | M7037 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 8.86e-05 | 200 | 236 | 9 | M7478 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | SLCO3A1 DBP THSD1 ITGAE TTC3 MPRIP PTPN12 TCF4 TMEM176B TNC ARHGEF5 NBEA ITIH5 CELSR3 LTBP2 LY75 TRIM47 ZMYM4 | 1.03e-04 | 721 | 236 | 18 | M1999 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | CTSC SLCO3A1 LRCH1 FMNL2 LANCL2 ITPKB NECTIN2 GOLGA3 TCF4 TNC PLEKHA4 SLC12A4 SEPTIN11 | 1.17e-04 | 418 | 236 | 13 | M12676 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TANC2 SOX12 NCKAP5 TBC1D8B FREM1 TDRD3 FAT2 PTPN12 STARD9 PCDH10 TCF4 TNC SGK1 PCDHB13 PCDHB12 PCDHB10 PSD3 PCDHB3 NBEA RUNX1 TFAP2C CLDN23 PCDHB16 SLCO5A1 EGFR ARHGAP28 LY75 | 7.67e-07 | 850 | 233 | 27 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | CPED1 HOXC9 TRPM5 MLPH DPP4 TNC PCDHB9 ITIH5 LHX1 LTBP2 TMC5 AHNAK2 | 9.58e-06 | 230 | 233 | 12 | gudmap_developingGonad_P2_epididymis_1000_k2 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | CTSC GATA6 COL6A5 TBC1D8B CPED1 ABCA8 DOCK5 ARAP2 DPP4 TMEM176B PSD3 MUC16 EBF1 ITIH5 RNASEL EGFR SUSD2 CES3 LTBP2 ELN CTSB AHNAK2 | 5.04e-05 | 778 | 233 | 22 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SYN3 EVC NCKAP5 TBC1D8B KIAA1549L STARD9 GLI3 VPS35L PLD1 PCDH10 TCF7L2 HECTD4 PSD3 NBEA SLCO5A1 C2CD3 CNTNAP2 DCHS1 MAST1 CFAP69 CDH4 | 6.13e-05 | 732 | 233 | 21 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_2500_k-means-cluster#3 | PCDHGC5 PCDHGC4 PCDHGA2 PCDHB14 PCDHB13 PCDHB12 PCDHB10 PCDHB9 PCDHB3 | 6.43e-05 | 158 | 233 | 9 | PP_RBC_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | HOXC9 TRPM5 PCDH10 DPP4 PCDHB12 PCDHB9 ITIH5 LHX1 PTCH2 AHNAK2 | 6.71e-05 | 197 | 233 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | DBP TRPM5 ANAPC1 GLI3 PCDH10 SZT2 TNC PCDHB12 PCDHB7 PCDHB3 APC LAMA3 TFAP2C CLDN23 PLPP6 SLCO5A1 C2CD3 EGFR CES3 ARHGAP28 CTSB CFAP69 | 8.46e-05 | 806 | 233 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 1.06e-04 | 23 | 233 | 4 | gudmap_kidney_e13.5_Podocyte_MafB_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.41e-04 | 175 | 233 | 9 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TANC2 NCKAP5 TBC1D8B TDRD3 PTPN12 PCDH10 TCF4 TNC PCDHB13 PCDHB12 PCDHB10 PSD3 PCDHB3 NBEA EBF1 RUNX1 TFAP2C CLDN23 PCDHB16 SLCO5A1 EGFR LY75 | 1.43e-04 | 836 | 233 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_top-relative-expression-ranked_200 | 1.45e-04 | 138 | 233 | 8 | gudmap_kidney_e13.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | ZNF672 GATA6 FMNL2 TDRD3 PLD1 SZT2 SLC39A10 RUNX1 CES3 ATP2B3 EPB41L1 | 1.82e-04 | 266 | 233 | 11 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CCP110 SPTBN2 NCKAP5 MPRIP PLEKHH1 UBE4A PCDH10 CSNK1E CNTNAP2 MAST1 | 2.00e-04 | 225 | 233 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#4 | GRAMD1B STARD9 ZMIZ2 MLPH PGGHG RGL3 PLEKHA4 JPH2 PCDHB16 ITIH5 SLCO5A1 | 2.00e-04 | 269 | 233 | 11 | ratio_EB-blastocyst_vs_EB-fibro_2500_K4 |
| CoexpressionAtlas | cerebral cortex | MAG FRMPD4 SYN3 SPTBN2 ADAM11 CSMD2 FMNL2 LANCL2 PLEKHH1 KIAA1549L NAV3 CACNA1G PCDH10 DOCK3 PCDHGC5 PCDHGC4 PCDHGA7 PCDHB10 PCDHB9 PSD3 APC NBEA AMER3 SLC39A10 SHANK2 CELSR3 CNTNAP2 MAST1 CDH4 PCDHGC3 ATP2B3 | 2.15e-04 | 1428 | 233 | 31 | cerebral cortex |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | ZNF672 JADE3 GATA6 COL6A5 FMNL2 C9orf152 TDRD3 STARD9 PLD1 SHISA6 SZT2 HECTD4 ATG14 SLC39A10 RUNX1 DENND4C TGFB1I1 CAMKK2 RNASEL ATP2B3 EPB41L1 | 2.21e-04 | 803 | 233 | 21 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | TDRD3 PCDH10 TCF4 PCDHB13 PCDHB12 PCDHB10 PCDHB3 NBEA PCDHB16 SLCO5A1 | 2.31e-04 | 229 | 233 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.74e-04 | 234 | 233 | 10 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | SOX12 FAT2 PCDH10 TCF4 TNC PCDHB10 PCDHB3 NBEA RUNX1 TFAP2C CLDN23 SLCO5A1 EGFR LY75 | 2.90e-04 | 428 | 233 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | SOX12 PCDHB13 PCDHB12 PCDHB10 PCDHB3 NBEA PCDHB16 SLCO5A1 ARHGAP28 | 2.92e-04 | 193 | 233 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | ADAM11 LYST TBC1D9 DOCK5 CIITA ZMIZ2 ARAP2 DPP4 TMEM176B MINK1 RGS12 SLCO5A1 FUT4 | 3.27e-04 | 382 | 233 | 13 | GSM538248_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | FREM1 GLI3 NAV3 PLG PCDH10 TCF4 TCF7L2 PCDHB13 PCDHB12 PCDHB7 APC LAMA3 NBEA RUNX1 TFAP2C CLDN23 SLCO5A1 C2CD3 EGFR LY75 | 3.35e-04 | 769 | 233 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | TBC1D8B TDRD3 TRPM5 RALGPS2 PCDHB7 PCDHB3 NBEA EBF1 PCDHB16 EGFR PAPPA | 3.59e-04 | 288 | 233 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 COL6A5 CPED1 ABCA8 FREM1 COL6A6 TNC RALGPS2 PSD3 ARHGAP28 ELN SOD3 | 5.59e-10 | 193 | 236 | 12 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CTSC SIGLEC5 TBC1D9 DLEC1 TCF7L2 GDF15 SGK1 RUNX1 SIGLEC1 LY75 CTSB | 2.80e-09 | 176 | 236 | 11 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 C9orf152 PTPN12 PRUNE2 TCF7L2 SGK1 RUNX1 CES3 SIGLEC1 | 4.22e-09 | 183 | 236 | 11 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SLCO3A1 COL6A5 ABCA8 FREM1 COL6A6 TNC RALGPS2 PAPPA ELN CFAP69 | 7.76e-09 | 194 | 236 | 11 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPED1 ABCA8 FREM1 NAV3 TCF4 COL6A6 EBF1 PAPPA ARHGAP28 LTBP2 ELN | 1.06e-08 | 200 | 236 | 11 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CTSC SIGLEC5 TBC1D9 PTPN12 TCF7L2 GDF15 SGK1 RUNX1 LY75 CTSB | 3.89e-08 | 177 | 236 | 10 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 PTPN12 MLPH PRUNE2 TCF7L2 SGK1 RUNX1 LY75 | 4.81e-08 | 181 | 236 | 10 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 PTPN12 MLPH PRUNE2 TCF7L2 SGK1 RUNX1 LY75 | 5.07e-08 | 182 | 236 | 10 | be48ce85991bceeff938ba080e6bf9cc62176b05 |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | TANC2 CTSC FMNL2 PTPN12 MLPH TCF7L2 DENND4C ITIH5 SEPTIN11 EPB41L1 | 7.59e-08 | 190 | 236 | 10 | 9fc763d65470ba8858b973689c4d4358faab7dd3 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SLCO3A1 COL6A5 FREM1 COL6A6 TNC RALGPS2 PAPPA ELN SOD3 | 7.97e-08 | 191 | 236 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | TANC2 CTSC FMNL2 MLPH TCF7L2 PSD3 DENND4C ITIH5 SEPTIN11 EPB41L1 | 7.97e-08 | 191 | 236 | 10 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | SPTBN2 DCLRE1A PRUNE2 ARHGEF5 MUC16 NBEA SHROOM2 EGFR EPB41L1 AHNAK2 | 8.37e-08 | 192 | 236 | 10 | 8899d81306770adda893b5e146df1253971754c5 |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | SPTBN2 DCLRE1A PRUNE2 ARHGEF5 MUC16 NBEA SHROOM2 EGFR EPB41L1 AHNAK2 | 8.37e-08 | 192 | 236 | 10 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SLCO3A1 COL6A5 CPED1 FREM1 TNC RALGPS2 PAPPA ELN CFAP69 SOD3 | 8.37e-08 | 192 | 236 | 10 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | TANC2 CTSC FMNL2 MLPH TCF7L2 PSD3 RUNX1 DENND4C SEPTIN11 EPB41L1 | 8.79e-08 | 193 | 236 | 10 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 SLCO3A1 COL6A5 ABCA8 FREM1 COL6A6 TNC RALGPS2 ELN SOD3 | 9.23e-08 | 194 | 236 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | FRMPD4 OLFML2A HOXC9 KIAA1549L GLI3 TNC PLEKHA4 ITIH5 EGFR CNTNAP2 | 9.68e-08 | 195 | 236 | 10 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 197 | 236 | 10 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.06e-07 | 197 | 236 | 10 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-07 | 199 | 236 | 10 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | NCKAP5 CPED1 FMNL2 TBC1D9 CIITA TCF4 TMEM176B SGK1 SIGLEC1 CTSB | 1.17e-07 | 199 | 236 | 10 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.17e-07 | 199 | 236 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | NCKAP5 CPED1 FMNL2 TBC1D9 CIITA TCF4 TMEM176B SGK1 SIGLEC1 CTSB | 1.17e-07 | 199 | 236 | 10 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 236 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 236 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 236 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-07 | 153 | 236 | 9 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-07 | 172 | 236 | 9 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-07 | 176 | 236 | 9 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-07 | 176 | 236 | 9 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 180 | 236 | 9 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 180 | 236 | 9 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-07 | 180 | 236 | 9 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 180 | 236 | 9 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.54e-07 | 181 | 236 | 9 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-07 | 182 | 236 | 9 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-07 | 182 | 236 | 9 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-07 | 184 | 236 | 9 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.36e-07 | 184 | 236 | 9 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 ARHGAP39 RUNX1 EPB41L1 | 6.36e-07 | 184 | 236 | 9 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 ARHGAP39 RUNX1 EPB41L1 | 6.36e-07 | 184 | 236 | 9 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 SGK1 RUNX1 SIGLEC1 | 6.36e-07 | 184 | 236 | 9 | 8fa30789c9d583188667cf375d2218e392dd40bc |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 C9orf152 PTPN12 PRUNE2 TCF7L2 SGK1 RUNX1 | 6.36e-07 | 184 | 236 | 9 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.66e-07 | 185 | 236 | 9 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 SGK1 RUNX1 SIGLEC1 | 6.66e-07 | 185 | 236 | 9 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.96e-07 | 186 | 236 | 9 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 SGK1 ARHGAP39 RUNX1 | 6.96e-07 | 186 | 236 | 9 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TANC2 SIGLEC5 TBC1D9 PTPN12 PRUNE2 TCF7L2 SGK1 ARHGAP39 RUNX1 | 6.96e-07 | 186 | 236 | 9 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.96e-07 | 186 | 236 | 9 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-07 | 187 | 236 | 9 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 7.61e-07 | 188 | 236 | 9 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-07 | 188 | 236 | 9 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 188 | 236 | 9 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-07 | 188 | 236 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 188 | 236 | 9 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.96e-07 | 189 | 236 | 9 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.96e-07 | 189 | 236 | 9 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 189 | 236 | 9 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-07 | 189 | 236 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 189 | 236 | 9 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.96e-07 | 189 | 236 | 9 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 7.96e-07 | 189 | 236 | 9 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.32e-07 | 190 | 236 | 9 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-07 | 190 | 236 | 9 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | FRMPD4 SPTBN2 TTC3 ZBTB7A CARMIL2 AMER3 CELSR3 CNTNAP2 ATP2B3 | 8.32e-07 | 190 | 236 | 9 | 416de85d8841dac883faa6f5339b2fb461a09e82 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-07 | 191 | 236 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.07e-07 | 192 | 236 | 9 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | ABCA8 HOXC9 KIAA1549L PCDHB10 EGFR CNTNAP2 PAPPA ARHGAP28 LTBP2 | 9.47e-07 | 193 | 236 | 9 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | ABCA8 HOXC9 KIAA1549L PCDHB10 EGFR CNTNAP2 PAPPA ARHGAP28 LTBP2 | 9.47e-07 | 193 | 236 | 9 | e4ea7ce011a80b81b841c907719aa532bed39d2e |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | ABCA8 HOXC9 KIAA1549L PCDHB10 EGFR CNTNAP2 PAPPA ARHGAP28 LTBP2 | 9.47e-07 | 193 | 236 | 9 | cf2461af78f65616ce40d552ee9452295e3895ed |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.47e-07 | 193 | 236 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.89e-07 | 194 | 236 | 9 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-07 | 194 | 236 | 9 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 9.89e-07 | 194 | 236 | 9 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-06 | 195 | 236 | 9 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 195 | 236 | 9 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.03e-06 | 195 | 236 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 197 | 236 | 9 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.12e-06 | 197 | 236 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 197 | 236 | 9 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 197 | 236 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.12e-06 | 197 | 236 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 197 | 236 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-06 | 198 | 236 | 9 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 198 | 236 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-06 | 198 | 236 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-06 | 199 | 236 | 9 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.22e-06 | 199 | 236 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 1.22e-06 | 199 | 236 | 9 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 199 | 236 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CTSC FMNL2 TCF7L2 SLC39A10 DENND4C ITIH5 SEPTIN11 SIGLEC1 CTSB | 1.22e-06 | 199 | 236 | 9 | 8e9862907b15809d083216e7d6a0f435015e5d15 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 199 | 236 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 199 | 236 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.27e-06 | 200 | 236 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 200 | 236 | 9 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.27e-06 | 200 | 236 | 9 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-06 | 200 | 236 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | SOX12 ITPKB TDRD3 ZMIZ2 TCF7L2 MINK1 APC RGS12 EXOC5 SETD2 SEPTIN11 FUT4 | 7.59e-07 | 192 | 234 | 12 | 849_DN |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A | SYN3 INTS1 TFCP2L1 ZMIZ2 PLD1 DPP4 MINK1 RUNX1 ITIH5 CNTNAP2 CES3 PAPPA | 8.47e-07 | 194 | 234 | 12 | 6031_UP |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | CIITA ZMIZ2 PPP1R37 DOCK3 DNAJC4 SZT2 RALGPS2 PSD3 APC RUNX1 CES3 AHNAK2 | 1.05e-06 | 198 | 234 | 12 | 2878_UP |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | TUBGCP3 PPP1R37 KLK11 DNAJC4 PGGHG GDF15 RUNX1 RGS12 OVGP1 SLC20A2 PTCH2 AP4M1 | 1.11e-06 | 199 | 234 | 12 | 5820_UP |
| Drug | Sp 1 (pharmaceutical) | HIP1 MAML1 ZBTB7A TFCP2L1 TCF4 PCDHGC5 PCDHGC4 MAT2B GDF15 PCDHGA2 RGL3 RUNX1 TFAP2C CCNT1 SETD2 SCAP EGFR PAPPA PCDHGC3 | 4.34e-06 | 548 | 234 | 19 | CID000099040 |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | SOX12 GATA6 MAST2 TBC1D9 ARAP2 GDF15 RGS3 RNASEL CELSR3 SEPTIN11 ELN | 5.12e-06 | 192 | 234 | 11 | 2703_DN |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | EVC TDRD3 PTPN12 MINK1 APC RUNX1 TFAP2C EXOC5 EGFR SEPTIN11 ARHGAP28 | 5.65e-06 | 194 | 234 | 11 | 7538_DN |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | HIP1 THSD1 LYST FCHSD2 ZFYVE9 ZMIZ2 TFAP2C RGS12 SEPTIN11 FUT4 DCAF4 | 5.65e-06 | 194 | 234 | 11 | 3280_DN |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | SLCO3A1 TBC1D8B TBC1D9 OLFML2A KIAA1549L ZMIZ2 NAV3 RUNX1 RGS3 EGFR SEPTIN11 | 6.23e-06 | 196 | 234 | 11 | 4619_DN |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | HIP1 SLCO3A1 TBC1D8B GRAMD1B ZMIZ2 RUNX1 CBS TFAP2C CELSR3 CSNK1E PLK4 | 6.23e-06 | 196 | 234 | 11 | 5111_UP |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | ZFYVE9 SCN4A PPP1R37 MIA3 PGGHG TEX14 RGS12 SHANK2 SLC20A2 CES3 LRP3 | 6.54e-06 | 197 | 234 | 11 | 2839_UP |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | NCOA3 CPED1 TDRD3 ZMIZ2 APC RUNX1 MLYCD CNTNAP2 SEPTIN11 ARHGAP28 CFAP69 | 6.54e-06 | 197 | 234 | 11 | 3763_DN |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | LYST OLFML2A ZFYVE9 TCF7L2 MINK1 PSD3 APC TGFB1I1 CNTNAP2 CES3 EPB41L1 | 6.87e-06 | 198 | 234 | 11 | 5413_DN |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | SPTBN2 THSD1 PLD1 RALGPS2 SIK3 RUNX1 RGS12 CCNT1 PAPPA ARHGAP28 CFAP69 | 6.87e-06 | 198 | 234 | 11 | 4422_UP |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | TANC2 PTPN12 CIITA ZMIZ2 PLD1 KLK11 TCF7L2 GDF15 RUNX1 LTBP2 TMC5 | 6.87e-06 | 198 | 234 | 11 | 2983_DN |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | MAML1 ZMIZ2 PLD1 DNAJC4 TCF7L2 APC RUNX1 TGFB1I1 OVGP1 CES3 FUT4 | 6.87e-06 | 198 | 234 | 11 | 5433_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | LYST ZFYVE9 ZMIZ2 SLC35A2 PGGHG INPP5E MINK1 RGS3 CCNT1 LTBP2 TMC5 | 7.20e-06 | 199 | 234 | 11 | 1536_DN |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | HIP1 ATP7B OLFML2A ZBTB7A TUBGCP3 SLC35A2 TCF7L2 SHANK2 CTSB PLK4 EPB41L1 | 7.20e-06 | 199 | 234 | 11 | 1493_DN |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | SLCO3A1 MAST2 ZFYVE9 PPP1R37 PLD1 TCF4 APC TGFB1I1 LHX1 CNTNAP2 TMC5 | 7.55e-06 | 200 | 234 | 11 | 6405_DN |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.08e-05 | 183 | 234 | 10 | 7443_UP | |
| Drug | AC1L1UVI | 2.10e-05 | 55 | 234 | 6 | CID000061263 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | SOX12 MAML1 LRCH1 ITPKB MINK1 PSD3 SLC20A2 LTBP2 FUT4 AHNAK2 | 2.87e-05 | 190 | 234 | 10 | 3468_UP |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | TDRD3 KIAA1549L DCLRE1A DPP4 TCF4 TCF7L2 CNTNAP2 SEPTIN11 LTBP2 EPB41L1 | 3.00e-05 | 191 | 234 | 10 | 4471_DN |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | MAST2 VPS35L NPAT MIA3 TCF7L2 PGGHG PSD3 SEPTIN11 FUT4 AHNAK2 | 3.14e-05 | 192 | 234 | 10 | 3318_DN |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | DOCK5 OLFML2A ZBTB7A SLC35A2 PGGHG INPP5E SETD2 EGFR FUT4 AHNAK2 | 3.14e-05 | 192 | 234 | 10 | 3375_DN |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.28e-05 | 193 | 234 | 10 | 4536_UP | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A | 3.43e-05 | 194 | 234 | 10 | 7537_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 6440_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 4105_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 2475_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 3735_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | TBC1D8B CPED1 TFCP2L1 PTPN12 APC RUNX1 TFAP2C CCNT1 OVGP1 SEPTIN11 | 3.58e-05 | 195 | 234 | 10 | 3663_DN |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 3.58e-05 | 195 | 234 | 10 | 429_UP | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | SLCO3A1 DBP TFCP2L1 ZMIZ2 CACNA1G PLD1 DOCK3 MINK1 RUNX1 PAPPA | 3.74e-05 | 196 | 234 | 10 | 3998_UP |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | SOX12 MAST2 LRCH1 ZBTB7A ZFYVE9 LAMA3 MLYCD CCNT1 CELSR3 FUT4 | 3.74e-05 | 196 | 234 | 10 | 5293_DN |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | HIP1 JADE3 MAST2 TUBGCP3 SLC35A2 SZT2 APC RUNX1 SEPTIN11 PLK4 | 3.74e-05 | 196 | 234 | 10 | 2473_DN |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | INTS1 LRCH1 FAT2 PRUNE2 RUNX1 RGS12 PAPPA ARHGAP28 ELN SIGLEC1 | 3.74e-05 | 196 | 234 | 10 | 3820_UP |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | SOX12 HIP1 ZFYVE9 TUBGCP3 MINK1 RUNX1 EGFR SEPTIN11 FUT4 AHNAK2 | 3.74e-05 | 196 | 234 | 10 | 1639_UP |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; HL60; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 2571_DN | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; HL60; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 2724_UP | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 5016_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | MAST2 ITPKB KIAA1549L VPS35L DPP4 TCF4 GDF15 APC SHROOM2 SLC20A2 | 3.74e-05 | 196 | 234 | 10 | 2099_DN |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; HL60; HT_HG-U133A | SLCO3A1 SLC35A2 RNF10 PGGHG RUNX1 CCNT1 C2CD3 CELSR3 CSNK1E SLC20A2 | 3.74e-05 | 196 | 234 | 10 | 2431_DN |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 4231_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 2493_DN | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 3210_UP | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; HL60; HT_HG-U133A | SOX12 ZFYVE9 TMEM176B PSD3 APC SHANK2 CSNK1E CFAP69 DCAF4 EPB41L1 | 3.91e-05 | 197 | 234 | 10 | 3074_UP |
| Drug | prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 6547_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; MCF7; HT_HG-U133A | SOX12 ITPKB ZBTB7A TUBGCP3 ARAP2 MINK1 RGS3 SETD2 CELSR3 EPB41L1 | 3.91e-05 | 197 | 234 | 10 | 7341_DN |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 5201_DN | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | IL22RA1 OLFML2A ZFYVE9 ZMIZ2 PRUNE2 DNAJC4 RGS12 CELSR3 EGFR ELN | 3.91e-05 | 197 | 234 | 10 | 3138_UP |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 6358_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 5475_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 5537_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 3583_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | TANC2 KIAA1549L SLC35A2 TCF4 APC CBS MSL2 CNTNAP2 CFAP69 PLK4 | 4.08e-05 | 198 | 234 | 10 | 7557_DN |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | DBP ITPKB TDRD3 TCF7L2 INPP5E TFAP2C RNASEL SHANK2 CELSR3 EGFR | 4.08e-05 | 198 | 234 | 10 | 5526_DN |
| Drug | topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 4.08e-05 | 198 | 234 | 10 | 915_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 4.26e-05 | 199 | 234 | 10 | 3381_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 4.26e-05 | 199 | 234 | 10 | 7148_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | SPTBN2 SLCO3A1 BCR TBC1D9 ZBTB7A PRUNE2 RGS12 OVGP1 EGFR LRP3 | 4.26e-05 | 199 | 234 | 10 | 7298_UP |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 4.26e-05 | 199 | 234 | 10 | 3822_UP | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; PC3; HT_HG-U133A | TDRD3 VPS35L DPP4 RUNX1 CCNT1 SHANK2 CNTNAP2 CFAP69 EPB41L1 SOD3 | 4.26e-05 | 199 | 234 | 10 | 5866_DN |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 4.26e-05 | 199 | 234 | 10 | 4555_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 4.44e-05 | 200 | 234 | 10 | 2670_DN | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 4.44e-05 | 200 | 234 | 10 | 5730_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | DOCK5 NECTIN2 SLC35A2 PLD1 TCF4 RALGPS2 APC TFAP2C CELSR3 CFAP74 | 4.44e-05 | 200 | 234 | 10 | 2190_UP |
| Drug | montmorillonite | 5.39e-05 | 40 | 234 | 5 | CID000517273 | |
| Drug | ptaquiloside | 7.18e-05 | 133 | 234 | 8 | ctd:C043680 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 7.22e-05 | 171 | 234 | 9 | 7535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.82e-05 | 178 | 234 | 9 | 7245_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 179 | 234 | 9 | 3388_DN | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; PC3; HT_HG-U133A | 1.26e-04 | 184 | 234 | 9 | 4439_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.49e-04 | 188 | 234 | 9 | 3823_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.55e-04 | 189 | 234 | 9 | 5675_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | TANC2 SPTBN2 PTPN12 TCF4 TCF7L2 TFAP2C EXOC5 CNTNAP2 SEPTIN11 | 1.55e-04 | 189 | 234 | 9 | 3788_DN |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.55e-04 | 189 | 234 | 9 | 4430_UP | |
| Drug | o-dianisidine | 1.60e-04 | 50 | 234 | 5 | CID000008411 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.61e-04 | 190 | 234 | 9 | 4493_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.61e-04 | 190 | 234 | 9 | 7145_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.67e-04 | 191 | 234 | 9 | 4811_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.74e-04 | 192 | 234 | 9 | 5567_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; HL60; HT_HG-U133A | 1.74e-04 | 192 | 234 | 9 | 2146_UP | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | TFCP2L1 PRUNE2 SAMD4B RUNX1 RGS12 CAMKK2 CNTNAP2 SEPTIN11 PLK4 | 1.74e-04 | 192 | 234 | 9 | 6728_UP |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 1.81e-04 | 193 | 234 | 9 | 7229_UP | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 1.81e-04 | 193 | 234 | 9 | 6869_DN | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.81e-04 | 193 | 234 | 9 | 2482_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.81e-04 | 193 | 234 | 9 | 2093_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 4828_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 3606_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 6380_DN | |
| Drug | Rgd Peptide | 1.94e-04 | 239 | 234 | 10 | CID000104802 | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 7058_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 7254_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 2223_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 4508_DN | |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 2290_UP | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | NCOA3 MAST2 ZFYVE9 ZNF394 KIAA1549L MINK1 MSL2 SETD2 CNTNAP2 | 1.96e-04 | 195 | 234 | 9 | 6561_UP |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 1823_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 5070_DN | |
| Disease | childhood trauma measurement, alcohol consumption measurement | TANC2 OSBPL5 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 PCDHGC3 | 6.86e-08 | 71 | 224 | 8 | EFO_0007878, EFO_0007979 |
| Disease | lymphocyte count | SIGLEC5 DBP BCR FMNL2 LYST GRAMD1B ZBTB7A PTPN12 ANAPC1 NECTIN2 GOLGA3 TCF4 TCF7L2 CARMIL2 PCDHGC5 PCDHGC4 PCDHGA7 PCDHGA5 PCDHGA2 MINK1 HECTD4 PSD3 JPH2 EBF1 SETD2 EGFR PAPPA LTBP2 SIGLEC1 PCDHGC3 | 7.86e-07 | 1464 | 224 | 30 | EFO_0004587 |
| Disease | mean platelet volume | LRCH1 MPRIP DOCK5 GRAMD1B UBN1 ZMIZ2 NECTIN2 PCDHGC5 PCDHGC4 COL6A6 PCDHGA7 PCDHGA5 PCDHGA2 PSD3 ATG14 EBF1 SIK3 RUNX1 RGS3 RGS12 SETD2 LY75 PCDHGC3 | 3.59e-06 | 1020 | 224 | 23 | EFO_0004584 |
| Disease | monocyte count | CTSC SPTBN2 SIGLEC5 MAST2 LYST CHST13 CIITA ZMIZ2 PLG NPAT DPP4 TCF4 TCF7L2 SZT2 SIGLEC14 ARHGAP9 EBF1 RUNX1 MEI1 SETD2 EGFR CES3 MAST1 ELN CTSB | 2.64e-05 | 1320 | 224 | 25 | EFO_0005091 |
| Disease | cortical surface area measurement | TANC2 DCHS2 NCKAP5 MAST2 BCR LRCH1 CPED1 FMNL2 MPRIP GLI3 VPS35L NAV3 DPP4 TCF4 TCF7L2 INPP5E RALGPS2 APC EBF1 ARHGAP39 CLDN23 ITIH5 EGFR PAPPA ARHGAP28 | 3.59e-05 | 1345 | 224 | 25 | EFO_0010736 |
| Disease | Intellectual Disability | TANC2 FRMPD4 KMT2C SLC5A6 SLC35A2 CACNA1G INPP5E APC NBEA SETD2 SHANK2 AP4M1 EPB41L1 | 4.17e-05 | 447 | 224 | 13 | C3714756 |
| Disease | cortical thickness | SPTBN2 NCKAP5 MAST2 LRCH1 CPED1 FMNL2 DUOX1 UBN1 GLI3 NAV3 DLEC1 DPP4 TCF4 TCF7L2 INPP5E RALGPS2 TACC2 EBF1 PCDHB16 ITIH5 EGFR ELN | 4.42e-05 | 1113 | 224 | 22 | EFO_0004840 |
| Disease | response to surgery | 5.74e-05 | 2 | 224 | 2 | EFO_0009951 | |
| Disease | Pitt-Hopkins syndrome (is_implicated_in) | 5.74e-05 | 2 | 224 | 2 | DOID:0060488 (is_implicated_in) | |
| Disease | pulse pressure measurement | HIP1 CHD2 MAST2 LRCH1 ZBTB7A KIAA1549L DCLRE1A DLEC1 TCF4 TCF7L2 RGL3 RALGPS2 JPH2 NBEA EBF1 SLC39A10 MEI1 SYT10 CLDN23 DENND4C SLC20A2 LTBP2 ELN DOT1L CFAP69 | 6.24e-05 | 1392 | 224 | 25 | EFO_0005763 |
| Disease | waist-hip ratio | SLCO3A1 CPED1 MPRIP OLFML2A UBN1 CIITA GLI3 SCN4A NAV3 DLEC1 PLD1 SHISA6 PRUNE2 DPP4 TCF7L2 HECTD4 EBF1 SIK3 RUNX1 CAMKK2 LTBP2 DOT1L ZMYM4 | 6.52e-05 | 1226 | 224 | 23 | EFO_0004343 |
| Disease | Neurodevelopmental Disorders | 7.87e-05 | 93 | 224 | 6 | C1535926 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 9.37e-05 | 60 | 224 | 5 | EFO_0022237 | |
| Disease | alkaline phosphatase measurement | EVC ITPKB ZBTB7A GLI3 NECTIN2 RNF10 PPP1R37 TMEM176B PGGHG GDF15 INPP5E MINK1 PSD3 USP43 EBF1 RUNX1 CLDN23 MLYCD LTBP2 CTSB | 1.04e-04 | 1015 | 224 | 20 | EFO_0004533 |
| Disease | C-reactive protein measurement | DCHS2 HIP1 IL22RA1 ZMIZ2 SLC5A6 SCN4A NECTIN2 RNF10 PPP1R37 KIAA2012 DOCK3 TCF4 TCF7L2 PSD3 EBF1 CLDN23 MLYCD MSL2 CAMKK2 CTSB CDH4 DCAF4 | 1.41e-04 | 1206 | 224 | 22 | EFO_0004458 |
| Disease | PITT-HOPKINS SYNDROME | 1.71e-04 | 3 | 224 | 2 | C1970431 | |
| Disease | Abnormality of refraction | SYN3 PKD1L1 EVC ITPKB GRAMD1B GLI3 DLEC1 SHISA6 DOCK3 TCF4 TCF7L2 NBEA EBF1 RUNX1 RGS3 | 2.13e-04 | 673 | 224 | 15 | HP_0000539 |
| Disease | Prostatic Neoplasms | NCOA3 ATP7B KMT2C ZBTB7A NECTIN2 GDF15 ARHGEF5 APC RUNX1 SETD2 CAMKK2 RNASEL EGFR CTSB | 2.84e-04 | 616 | 224 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 ATP7B KMT2C ZBTB7A NECTIN2 GDF15 ARHGEF5 APC RUNX1 SETD2 CAMKK2 RNASEL EGFR CTSB | 2.84e-04 | 616 | 224 | 14 | C0376358 |
| Disease | brain measurement, neuroimaging measurement | DCHS2 NCKAP5 LRCH1 CPED1 NAV3 DPP4 TCF4 TCF7L2 TANK RALGPS2 ITIH5 EGFR PAPPA | 3.23e-04 | 550 | 224 | 13 | EFO_0004346, EFO_0004464 |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 3.41e-04 | 4 | 224 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Gastrointestinal Neoplasms | 3.41e-04 | 4 | 224 | 2 | C0017185 | |
| Disease | collectin-12 measurement | 3.41e-04 | 4 | 224 | 2 | EFO_0020272 | |
| Disease | Malignant neoplasm of gastrointestinal tract | 3.41e-04 | 4 | 224 | 2 | C0685938 | |
| Disease | Glioblastoma | 3.44e-04 | 79 | 224 | 5 | C0017636 | |
| Disease | potassium measurement | 3.77e-04 | 45 | 224 | 4 | EFO_0009283 | |
| Disease | disorder of pharynx | 4.11e-04 | 46 | 224 | 4 | MONDO_0020592 | |
| Disease | corneal hysteresis | 4.47e-04 | 20 | 224 | 3 | EFO_0010066 | |
| Disease | Giant Cell Glioblastoma | 4.57e-04 | 84 | 224 | 5 | C0334588 | |
| Disease | Global developmental delay | 5.51e-04 | 133 | 224 | 6 | C0557874 | |
| Disease | neuroimaging measurement | DCHS2 NCKAP5 BCR LRCH1 GLI3 NAV3 PLD1 TCF4 TCF7L2 SZT2 RALGPS2 APC TACC2 DENND4C ITIH5 EGFR PAPPA TMC5 TRIM47 | 5.55e-04 | 1069 | 224 | 19 | EFO_0004346 |
| Disease | Klatskin's tumor (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.69e-04 | 243 | 224 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | ovarian neoplasm | 5.73e-04 | 134 | 224 | 6 | C0919267 | |
| Disease | Alzheimer disease, polygenic risk score | ATP7B MAST2 ITPKB NECTIN2 PPP1R37 DOCK3 PCDHGA5 PCDHGA2 PSD3 TACC2 CNTNAP2 LY75 DCAF4 | 5.85e-04 | 586 | 224 | 13 | EFO_0030082, MONDO_0004975 |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 6.11e-04 | 51 | 224 | 4 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 6.11e-04 | 51 | 224 | 4 | EFO_0022240 | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.29e-04 | 189 | 224 | 7 | EFO_0009932 | |
| Disease | serum albumin measurement | ABCA8 CIITA DOCK3 MIA3 TCF7L2 TMEM176B PSD3 EBF1 SIK3 RUNX1 RGS12 MLYCD MSL2 | 6.43e-04 | 592 | 224 | 13 | EFO_0004535 |
| Disease | Malignant neoplasm of ovary | 6.44e-04 | 137 | 224 | 6 | C1140680 | |
| Disease | Sarcosine measurement | 6.83e-04 | 23 | 224 | 3 | EFO_0021668 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 7.07e-04 | 53 | 224 | 4 | EFO_0022286 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 7.77e-04 | 24 | 224 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | aortic valve disease (implicated_via_orthology) | 8.43e-04 | 6 | 224 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | Eye Diseases, Hereditary | 8.43e-04 | 6 | 224 | 2 | C0015398 | |
| Disease | N1-methyladenosine measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0021122 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 8.72e-04 | 56 | 224 | 4 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 8.72e-04 | 56 | 224 | 4 | EFO_0022251 | |
| Disease | mental development measurement | 8.78e-04 | 25 | 224 | 3 | EFO_0008230 | |
| Disease | breast cancer (implicated_via_orthology) | 8.78e-04 | 25 | 224 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | facial morphology measurement | DCHS2 BCR CPED1 ERBIN PTPN12 ANAPC1 GLI3 NAV3 PCDH10 TCF4 TCF7L2 | 9.33e-04 | 466 | 224 | 11 | EFO_0007841 |
| Disease | urate measurement, bone density | COL6A5 ERBIN ABCA8 FREM1 ITPKB DOCK5 GRAMD1B C9orf152 TCF7L2 PSD3 RUNX1 POLR3E CDH4 | 9.66e-04 | 619 | 224 | 13 | EFO_0003923, EFO_0004531 |
| Disease | triglycerides to total lipids in small LDL percentage | 1.06e-03 | 59 | 224 | 4 | EFO_0022337 | |
| Disease | Rectal Neoplasms | 1.17e-03 | 7 | 224 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 1.17e-03 | 7 | 224 | 2 | C0007113 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.36e-03 | 63 | 224 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.36e-03 | 63 | 224 | 4 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.36e-03 | 63 | 224 | 4 | EFO_0022283 | |
| Disease | diabetes mellitus (is_implicated_in) | 1.36e-03 | 29 | 224 | 3 | DOID:9351 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.44e-03 | 64 | 224 | 4 | EFO_0022253 | |
| Disease | lower face morphology measurement | 1.49e-03 | 109 | 224 | 5 | EFO_0010948 | |
| Disease | Epilepsy | 1.49e-03 | 109 | 224 | 5 | C0014544 | |
| Disease | Coronary Arteriosclerosis | 1.52e-03 | 65 | 224 | 4 | C0010054 | |
| Disease | Coronary Artery Disease | 1.52e-03 | 65 | 224 | 4 | C1956346 | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0008285 | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.56e-03 | 8 | 224 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 1.61e-03 | 111 | 224 | 5 | C1621958 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.62e-03 | 286 | 224 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | self rated health | 1.66e-03 | 31 | 224 | 3 | EFO_0004778 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.70e-03 | 67 | 224 | 4 | EFO_0022245 | |
| Disease | endometrial carcinoma | 1.74e-03 | 113 | 224 | 5 | EFO_1001512 | |
| Disease | susceptibility to chronic sinus infection measurement | 1.80e-03 | 68 | 224 | 4 | EFO_0008419 | |
| Disease | anthropometric measurement | 1.84e-03 | 168 | 224 | 6 | EFO_0004302 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.90e-03 | 69 | 224 | 4 | EFO_0022341 | |
| Disease | diastolic blood pressure, systolic blood pressure | MAML1 LRCH1 DOCK5 DLEC1 PLD1 RALGPS2 JPH2 ARHGAP9 SYT10 RGS12 PLPP6 C2CD3 ELN | 1.95e-03 | 670 | 224 | 13 | EFO_0006335, EFO_0006336 |
| Disease | Carcinoma, Granular Cell | 1.95e-03 | 116 | 224 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.95e-03 | 116 | 224 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.95e-03 | 116 | 224 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.95e-03 | 116 | 224 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.95e-03 | 116 | 224 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.95e-03 | 116 | 224 | 5 | C0001418 | |
| Disease | age at onset, coronary stenosis | 1.99e-03 | 9 | 224 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | Gastrointestinal Hemorrhage | 1.99e-03 | 9 | 224 | 2 | C0017181 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.99e-03 | 9 | 224 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | immunoglobulin M measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0020466 | |
| Disease | mean corpuscular hemoglobin concentration | MAG ATP7B SIGLEC5 SLC5A6 NECTIN2 SLC35A2 KIAA2012 PCDHGA5 HECTD4 PSD3 EBF1 RUNX1 EGFR SLC20A2 MAST1 DOT1L LY75 PLK4 | 2.04e-03 | 1105 | 224 | 18 | EFO_0004528 |
| Disease | Leukemia, Myelocytic, Acute | 2.13e-03 | 173 | 224 | 6 | C0023467 | |
| Disease | triglycerides to total lipids in small HDL percentage | 2.22e-03 | 72 | 224 | 4 | EFO_0022336 | |
| Disease | myeloid white cell count | MAST2 FMNL2 ZBTB7A PRUNE2 TCF4 TCF7L2 INPP5E HECTD4 EBF1 SIK3 CBS CCNT1 SETD2 CES3 DOT1L LY75 | 2.26e-03 | 937 | 224 | 16 | EFO_0007988 |
| Disease | age at first birth measurement | 2.27e-03 | 120 | 224 | 5 | EFO_0009101 | |
| Disease | colorectal cancer (is_implicated_in) | 2.35e-03 | 121 | 224 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | total blood protein measurement | NCOA3 ZBTB7A TCF7L2 INPP5E EBF1 RUNX1 RGS3 RGS12 SETD2 SIGLEC1 | 2.41e-03 | 449 | 224 | 10 | EFO_0004536 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.43e-03 | 239 | 224 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.46e-03 | 74 | 224 | 4 | EFO_0022280 | |
| Disease | medulloblastoma (is_implicated_in) | 2.48e-03 | 10 | 224 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 2.48e-03 | 10 | 224 | 2 | EFO_0801544 | |
| Disease | Fuchs endothelial corneal dystrophy | 2.48e-03 | 10 | 224 | 2 | Orphanet_98974 | |
| Disease | coffee consumption measurement, insomnia | 2.48e-03 | 10 | 224 | 2 | EFO_0004698, EFO_0006781 | |
| Disease | Liver Cirrhosis, Experimental | HIP1 SIGLEC5 BCR TBC1D9 PLEKHH1 NECTIN2 PLG PRUNE2 TCF4 ARHGAP9 NBEA RGS3 RNASEL CES3 | 2.52e-03 | 774 | 224 | 14 | C0023893 |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 2.56e-03 | 36 | 224 | 3 | EFO_0022257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHGSQLDSEPRSAPA | 786 | Q8N944 | |
| DHASFPPQLLPRSES | 1001 | Q96RT1 | |
| ASLFVNSHPGIDRPG | 261 | Q8WV16 | |
| FRPTEAFAPLDGHTQ | 371 | Q5SNV9 | |
| TPHGTSRLAPVLETN | 371 | Q92754 | |
| NARSRPSFHPLSDEL | 16 | P07858 | |
| LRGQSGIISSPHFPS | 206 | Q7Z408 | |
| ISPSLRPTFENALEH | 826 | A4D0V7 | |
| LVSPSSEHLGRSGPF | 381 | Q6ZNE5 | |
| HNLATVFGPTLLRPS | 1201 | P11274 | |
| QHPPRAAESELAFPS | 696 | P33076 | |
| SERPLSAPASHLNEA | 1116 | P35670 | |
| DPASSDHTTRLQPLG | 706 | Q6F5E8 | |
| SFPGSHRTEQTPDLV | 606 | Q12774 | |
| PEPSDATHLFSGRTF | 321 | O75078 | |
| RDFPTAEEPHLNLGS | 151 | Q8WZ64 | |
| SSQPSFKLEPTQGHR | 336 | O60563 | |
| SQDHTVPGRPAASEL | 786 | Q8TEK3 | |
| FDIDSGRNAPLHSPP | 951 | Q16720 | |
| STQTRHIPEDTPNGF | 601 | Q3KR37 | |
| GLGPASLSFELPRHT | 401 | O00189 | |
| GSDQRLPPEGDTHLF | 146 | Q5JTZ5 | |
| RVTAHDSGDPPLSSN | 531 | Q9Y5G6 | |
| NGEPPRSATATLHVL | 646 | Q9Y5E4 | |
| PRGASVFSVTAHDPD | 466 | Q9Y5H1 | |
| SHNVDLPESRIPGSN | 11 | Q9C0H5 | |
| DSTPLPNFLSGSHRP | 31 | P49796 | |
| PRGVSIFSVTAHDPD | 466 | Q9Y5G8 | |
| TLSGPHSTIRNFQDP | 221 | Q14207 | |
| GLLFERSASSHEVPP | 186 | Q9H1A4 | |
| LLESHRDPGPLFSTI | 486 | Q9NRD9 | |
| GSHFDVRIPPFSLES | 341 | Q9Y2S7 | |
| TLFHTSGQPRADNPS | 346 | Q92585 | |
| LNTRHPFSSPEPDSA | 701 | Q8WXI7 | |
| ASDHGSPPRSATQVL | 1621 | Q96JQ0 | |
| RDVNDHAPTFPTSPL | 1951 | Q96JQ0 | |
| DNGEPPRSATATLHV | 646 | Q9Y5F0 | |
| FSRPASVSENHDAGP | 436 | Q9H4G0 | |
| EDLLASRFPATGAHP | 21 | P31274 | |
| LRSEHSNGTVAPDSP | 166 | Q9BR39 | |
| LLAPDGTDFDNPVHR | 51 | Q6WCQ1 | |
| RQQSLGSAFGHSPPL | 366 | P10071 | |
| APPGSVVEASSNLRH | 2576 | Q8NEZ4 | |
| ADAFNLPSSHLRPIT | 266 | Q9NZL9 | |
| LRGEPPELDLSYSHS | 586 | P20916 | |
| GQLSFTDLGLPPTDH | 2776 | Q16787 | |
| TDLGLPPTDHLQASF | 2781 | Q16787 | |
| RLTEDPAGPSQNLTH | 851 | Q86UX2 | |
| LSGVASSSPNLPHRD | 161 | Q9NRR6 | |
| SSSPNLPHRDAAVAG | 166 | Q9NRR6 | |
| GQTFHSLLTASLPPR | 1301 | Q8N201 | |
| NFESPSHSPGLRSLA | 296 | P22083 | |
| TSRDLGSHDNLSPPF | 81 | P15884 | |
| GSHDNLSPPFVNSRI | 86 | P15884 | |
| FPSLHNLLEGTPQRS | 2301 | Q2LD37 | |
| HFLSDVLGPETSRFP | 426 | Q9NS86 | |
| QREFPHLGVFSSLSP | 316 | O95822 | |
| QDGSFSLARILSGHP | 556 | P38570 | |
| LRATDSGQPPLHEDT | 3396 | Q9NYQ8 | |
| VRDSGSPPLHANTSL | 536 | Q9Y5F6 | |
| HSSSDVTIGPRLFLP | 2231 | Q8IVL0 | |
| TDSHFPRQDQLPSFP | 1996 | Q5H8C1 | |
| LPAAQEDSSDPTLGH | 581 | Q0VF49 | |
| EQTRTATESFPHPGF | 116 | Q9UBX7 | |
| GSAIPPAFISARDHV | 121 | O75074 | |
| FPRTAAPGHDLSDTV | 86 | Q9Y2L9 | |
| EPSGRAANDPFTIVH | 26 | O60449 | |
| PSSEAQRFTDILAHP | 336 | P48742 | |
| RFRPSEPHFTLDGNS | 356 | P27487 | |
| TLFAQALPRDAHSTP | 116 | Q96CW5 | |
| SRASFPGPSELHSED | 36 | Q99988 | |
| PGPSELHSEDSRFRE | 41 | Q99988 | |
| APENSRGPALSAEHT | 156 | Q6ZVL6 | |
| FAAHSLPSDPRLLAT | 11 | Q32M88 | |
| SAFSPESPDLDLHQG | 136 | Q32M88 | |
| EAVAPGTRFPLESAH | 146 | Q9UN70 | |
| SNGDVSLRIPDHLPF | 381 | Q9Y5F7 | |
| NSTTFPSRHGLLLPA | 61 | Q96E09 | |
| SNAHGFLLDTSLEPP | 311 | Q13219 | |
| RDHGQPPLSSTATLV | 661 | Q9P2E7 | |
| DNGEPPRSATATLHL | 646 | Q9UN67 | |
| TDPVRPFISGHVANS | 1646 | Q9Y4D8 | |
| TSVDPYDRHLLPNSG | 266 | Q9BQ04 | |
| DPPAHSDLGSVRTFL | 161 | Q3MIN7 | |
| LQEDRSHSGPSSLPE | 11 | Q08378 | |
| SIDRFGINIPSPEHS | 201 | Q9HCI7 | |
| HLGSSPLDSPRNFSP | 56 | Q9Y2H9 | |
| DNGEPPRSATATLHV | 646 | Q9Y5F1 | |
| HGLPQISSRSPESLA | 661 | Q5TIA1 | |
| SDLGDPPRSSVIHLQ | 1906 | Q6V1P9 | |
| VRVLDANDHSPSFPT | 1921 | Q6V1P9 | |
| LDARNTPLLDHSAPF | 196 | O75864 | |
| PSFETALRLPASGTH | 6941 | Q5VST9 | |
| NGEPPRSATATLHVL | 646 | Q9Y5E5 | |
| SPLGTEFPLNHALDL | 146 | Q9NRJ7 | |
| DNGEPPRSATATLHV | 646 | Q9NRJ7 | |
| DNGEPPRSATATLHV | 646 | Q9Y5E9 | |
| DNGEPPRSATATLHV | 646 | Q9Y5E2 | |
| AGPFETPVLHSLQSR | 351 | Q92908 | |
| ILPVAFRGDSFTHTP | 371 | P00533 | |
| FRGDSFTHTPPLDPQ | 376 | P00533 | |
| NLPLGPSIDTHGETF | 396 | O00471 | |
| THLAVSFGRSVPEAP | 196 | Q969P0 | |
| SPRPAHFLDQPTAAS | 976 | Q4AC94 | |
| LSESNFGHSSEAPPR | 1896 | Q8IZD9 | |
| DNRLSPFHGSSPPQS | 1771 | Q9H7D0 | |
| PDSLHDAAQRTYGPL | 101 | P57796 | |
| SFDLPDTLQVPGLHR | 1171 | O43497 | |
| STLGQTDFPAHSRKP | 391 | O14647 | |
| TSSLDNEGPHPDLLS | 256 | A1L170 | |
| SEERAPGLPNHGATF | 1261 | Q14CM0 | |
| FHIAPTPLTSTLGDR | 2321 | A8TX70 | |
| AGPRLHLSPTFASLD | 766 | Q6NUI2 | |
| APEASRHLGAEQSPA | 71 | Q8IX06 | |
| TGLRDPFNPFELTNH | 391 | P53634 | |
| TPTNARFDSPESHVG | 191 | P35520 | |
| DPSGHFSVRTDPVTN | 436 | P55283 | |
| DPGNPSLHSRFVELS | 66 | Q9NNZ3 | |
| RSSLPLDHGSPAQEN | 1276 | Q5VZ89 | |
| SSHRPNPFRSLEPEG | 366 | Q7Z7H3 | |
| PIRTGHPTVLESNSD | 326 | O43303 | |
| RLDPSEGTPSYLEHA | 246 | Q9UH73 | |
| SIEDLHRGSNLPSPV | 171 | Q96PY5 | |
| SQPHGERFGSLQALP | 3486 | Q99698 | |
| FPNTAGHSADRTPIL | 1691 | Q14767 | |
| GHSADRTPILESPLQ | 1696 | Q14767 | |
| HTGNSPLDSPRNFSP | 196 | Q6P0Q8 | |
| EPAGAPQRHSLSEIT | 311 | Q8N6P7 | |
| DTAPTGHTLRLLNFP | 166 | O43681 | |
| VPLDTSGSQARPHLS | 81 | Q96RR4 | |
| DLALSSIPGHETFDP | 211 | Q10586 | |
| DEPLVSGLPHVAFSS | 36 | Q9UHC6 | |
| KFRPLADGSSNPSLH | 126 | P57679 | |
| LLAQSRAGDHPFSSP | 176 | Q6PJP8 | |
| AESPGFSQASRHTPE | 691 | O94868 | |
| GNSSPLPSDFLIRHH | 166 | Q9NYQ7 | |
| VEARDHGSPPLSASA | 726 | Q9NYQ7 | |
| THFARTGDPNSKALP | 501 | Q6UWW8 | |
| NHIFTRSLPFEGSQP | 191 | Q9BRP7 | |
| HLNDPDPSGQLLFRS | 246 | A5D8W1 | |
| PFDIEPSSGQLHSLG | 911 | Q9Y238 | |
| LSPELREGDPSSSQH | 621 | P15502 | |
| THTALSPLQFRGTPG | 1036 | Q12770 | |
| LPVHATFRAADSSAP | 396 | Q08357 | |
| FHNDSITPSERGEPS | 196 | Q9ULF5 | |
| SLPPGHTLFSGISDR | 591 | Q9NVU0 | |
| QPHLDVSPTLGSFRV | 1981 | Q8TDX9 | |
| DRKGSEPLSFSPHNT | 1211 | Q9C0B2 | |
| NHFLGDRDVLPAPAS | 136 | Q96B33 | |
| EPVFSPHLVSQGSFR | 691 | Q92613 | |
| TGDRVALLSHAPPDF | 2006 | A6NMZ7 | |
| QPTSISPSRHGALAE | 261 | Q9BV36 | |
| AFDTHTGTDARPQLP | 601 | Q68BL7 | |
| RFTGHNSPLFSLPED | 221 | Q12889 | |
| DNGEPPRSATATLHV | 646 | Q9Y5E6 | |
| RPGPLQTDLHAQSSE | 46 | A6NNC1 | |
| TFPNAGPRHLLDDSV | 361 | Q86X27 | |
| DNGEPPRSATATLHV | 646 | Q9Y5E1 | |
| QTTFLGSPGPRHERS | 741 | Q9H0X9 | |
| PTRNLAAFPASHDPD | 606 | Q8N4C8 | |
| ADHPGELVRTDSPNF | 56 | Q01196 | |
| SETPFHSRQRAPLPS | 1996 | Q5T011 | |
| ERRHPQPLAASFSSP | 41 | O14994 | |
| IPFTVSLDNGHSFPR | 126 | Q9UGT4 | |
| PASPIDPFQSRLDSH | 586 | Q96LD4 | |
| GHSAQELPTIRTPAD | 376 | O94763 | |
| DLGNARPSAPSTLFD | 261 | Q9H7E2 | |
| SPRVHSLFTEGTLDP | 571 | Q8IWB6 | |
| DSRDHIFAPGNPSSD | 871 | Q8WUY3 | |
| LFDGDPHLSTENPAL | 2266 | Q8WUY3 | |
| DGPPSSLELDHLNFI | 901 | P35499 | |
| FESDPATHNEPGVRL | 66 | Q9NVA2 | |
| NGVLRHPLEPDSSAS | 316 | Q9UIG8 | |
| PGQLDPSTGRRFSEH | 21 | Q5JRA6 | |
| ESSGPLFELRSDPHI | 851 | O14513 | |
| LFHPSSESEQGLTRP | 606 | Q13393 | |
| GPPLESTFHQSLETD | 351 | Q9H4M7 | |
| SQHGRISGFELDPDP | 236 | Q9Y289 | |
| TSTGPHRPQDLALTE | 311 | P27987 | |
| SDPERTLDPNSAFLH | 621 | P27987 | |
| SSDYPAPRAVLTGHD | 2766 | Q8NFP9 | |
| HAFTEALPGTPLQER | 476 | Q9Y6C5 | |
| VSGPNDLRHFDPEFT | 376 | O00141 | |
| PNFLRASALSEHISP | 296 | O00291 | |
| PSNPESFITRHDLSG | 261 | Q9Y6Q9 | |
| FRTPLSFTNPLHSDD | 591 | Q05209 | |
| RLLQPGPSEHSKSFD | 616 | Q05823 | |
| PLSTVSERVGHPDNA | 776 | Q9H2Y9 | |
| SELTLTPRPEDHGTN | 196 | O15389 | |
| EGRSAPSSEPHLIFV | 641 | O75182 | |
| GHSDIRLPPTEFAQL | 981 | Q9Y2K2 | |
| SQHVSGDASRPLPEA | 1136 | Q13796 | |
| LHSQDPLLSPERTAF | 401 | Q6ZSJ9 | |
| PLLHSQSVGLRFSPS | 1771 | Q9HCD6 | |
| NDSTFLHSTPERPGI | 241 | Q92844 | |
| DGNSPVRSHVDVPLS | 396 | G3V0H7 | |
| RHINVSFALPSGPEL | 1711 | Q9P2P6 | |
| DHAFRPDSSGNPLPS | 2096 | Q9P2P6 | |
| EALPVGSDHLLPSAS | 296 | Q9NZI6 | |
| RFSPATHPSEGLEEN | 136 | P00747 | |
| DSISPNRDFQGHPDL | 496 | O00444 | |
| TFSIPGTLESGHPRN | 276 | Q96PQ1 | |
| GNHRESSPFLSPLEA | 41 | Q9UP95 | |
| FLFHPGDTVPSTARI | 46 | Q3YBM2 | |
| PQLSSHRGDLITEPF | 371 | P78381 | |
| FHDPETGETPLTLAA | 191 | Q9UPX8 | |
| DEPTAGLDPFSRHQV | 641 | O94911 | |
| GFPSSRLDLTGPHFE | 4766 | Q8IVF2 | |
| GISLGSPFHLTPDQE | 2141 | P25054 | |
| QEAHAPGRLPSLADF | 141 | Q8NET6 | |
| APHVAQRSTSPEAGL | 616 | Q70EL4 | |
| ASPDPETSRLHFRQL | 56 | Q53GI3 | |
| SRSVLPDHFSPENAN | 256 | Q7Z3J2 | |
| EGSPPFEAAHQTDRF | 481 | O14924 | |
| AGPPAFSLHEVSRVL | 456 | Q9NZQ8 | |
| PLLGQQRLEHSSFPE | 2151 | O15020 | |
| LGARAAFTTPDHAPL | 256 | Q5PRF9 | |
| LRRSLPEHPAFQSDT | 536 | Q0IIM8 | |
| STHTPAPGFLEDASR | 161 | C9JR72 | |
| GFPTEPNSSSRAIHV | 101 | P08294 | |
| DRDPDLQPPSGTSHF | 271 | O15370 | |
| NESLHPPAFSRSNSE | 56 | Q9P2N2 | |
| PLSRSPGSHADFLLT | 671 | Q8N5U6 | |
| HFQEASGTRGPLNPL | 711 | Q9NS62 | |
| QARAHPLGTTSDPAA | 146 | Q499Z4 | |
| LPNGSLSPTARTLHF | 116 | Q9NQB0 | |
| GSSNALDRHDPSLPY | 846 | Q6ZT07 | |
| RTAHISGLPPSTDFI | 1491 | P24821 | |
| SDSAGPFAVPDHLRQ | 1061 | P53804 | |
| TLFRPEQETSDPAAH | 716 | Q9BRR9 | |
| HLPRSNSGAAPEAEV | 311 | O95359 | |
| LATSLGPQVPSHGRF | 836 | Q9BZZ2 | |
| HPLLELPGRATSFDS | 496 | Q6XYQ8 | |
| EAFSALHPSGLPELE | 351 | Q9ULM0 | |
| SESPVHRRGSFPLAA | 61 | Q8IY26 | |
| RLPELSHPQSDGVDS | 1156 | Q9BYW2 | |
| LGLPSHAARPSTDFT | 131 | Q8NF64 | |
| LEHLLSESPEGSPFR | 316 | Q9NPG3 | |
| LPQEPSFRGISEHES | 206 | Q8NF99 | |
| SDPSNSIDGPDHLRS | 306 | Q9Y2L5 | |
| SDFRVQNHLPASGPT | 166 | O43294 | |
| IQPSFRHRSDDPVGS | 271 | Q6UXY8 | |
| RHLLSDQTDPFNRSP | 1021 | Q14139 | |
| SRIGSTTNPFLDIPH | 766 | Q9NYI0 | |
| SELTLTPRPEDHGTN | 196 | Q08ET2 | |
| SPRSDPLGSTQDHAL | 1241 | Q5VZL5 | |
| DPPSHRLSFNPTLAS | 41 | O95405 | |
| IPFPDHSSDILSGLN | 11 | O95365 | |
| PNGPTHSSTLFVRDD | 11 | Q9NYB0 | |
| RIPASQTSVPFDHLG | 401 | P49674 | |
| RPVSPGISDANDHDL | 101 | A8MZ59 | |
| PSQLFTLGASEHSPL | 421 | Q92692 |